Poway, CA, United States of America

Jeffrey A Shimizu

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 9.5

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2021-2024

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Jeffrey A. Shimizu

Introduction

Jeffrey A. Shimizu is a notable inventor based in Poway, California, recognized for his significant contributions to the field of medical technology. With a total of five patents to his name, Shimizu has focused on developing ingestible devices that enhance therapeutic delivery to the gastrointestinal tract. His work aims to improve patient outcomes through innovative solutions.

Latest Patents

One of Shimizu's latest patents is an ingestible device designed for the delivery of therapeutic agents directly to specific tissues within the gastrointestinal tract. This device targets areas such as the submucosa, mucosa, and mucus layer, ensuring that therapeutic agents are delivered safely and effectively. The patent also includes pharmaceutical compositions intended for treating various diseases or conditions in patients who require such interventions.

Career Highlights

Throughout his career, Jeffrey A. Shimizu has worked with prominent companies in the biotechnology sector, including Biora Therapeutics, Inc. and Progenity, Inc. His experience in these organizations has allowed him to refine his expertise in developing innovative medical devices that address critical health challenges.

Collaborations

Shimizu has collaborated with several professionals in his field, including Mitchell Lawrence Jones and Mark Sasha Drlik. These partnerships have contributed to the advancement of his projects and the successful development of his patented technologies.

Conclusion

Jeffrey A. Shimizu's work exemplifies the spirit of innovation in medical technology. His patents and collaborations reflect a commitment to improving therapeutic delivery methods, ultimately benefiting patients in need of effective treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…